| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized study of epirubicin monotherapy every four or every two
weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group
study
|
G. Fountzilas
|
|
1997
|
8 |
12 |
p. 1213-1220
8 p.
|
artikel
|
| 2 |
Cardiac arrhythmias after cisplatin infusion: Three case reports and a
review of the literature
|
D. Tassinari
|
|
1997
|
8 |
12 |
p. 1263-1267
5 p.
|
artikel
|
| 3 |
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy
and stem cell support: A retrospective multicenter study of the Austrian Study
Group on Urologic Oncology
|
J. Pont
|
|
1997
|
8 |
12 |
p. 1229-1234
6 p.
|
artikel
|
| 4 |
Clinical oncology: Basic principles and practice. A. J. Neal, P. J. Hoskin (eds).
|
F. R. Hirsch
|
|
1997
|
8 |
12 |
p. 1284-1284
1 p.
|
artikel
|
| 5 |
Colony-stimulating factors. Molecular and cellular biology. J. M. Garland, P. J. Quesenberry, D. J. Hilton (eds).
|
A. M. Gianni
|
|
1997
|
8 |
12 |
p. 1176-1176
1 p.
|
artikel
|
| 6 |
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice
bearing human tumor xenografts that overexpress the multidrug resistance
protein (MRP)
|
U. Vanhoefer
|
|
1997
|
8 |
12 |
p. 1221-1228
8 p.
|
artikel
|
| 7 |
Correlation between physical performance and fatigue in cancer
patients
|
F. Dimeo
|
|
1997
|
8 |
12 |
p. 1251-1255
5 p.
|
artikel
|
| 8 |
Differences in docetaxel and paclitaxel activity in resistant tumor cells
which express MRP: Need of comparative clinical trials in resistant
patients
|
M. DIncalci
|
|
1997
|
8 |
12 |
p. 1183-1184
2 p.
|
artikel
|
| 9 |
Do authors of review articles use systematic methods to identify, assess
and synthesize information?
|
V. H. C. Bramwell
|
|
1997
|
8 |
12 |
p. 1185-1195
11 p.
|
artikel
|
| 10 |
Ecco in Hamburg: A huge success; EU strives to prepare new directive
concerning tobacco advertising; Middle East cancer consortium: NCI starts to
pay; BIG begins to work; EU: Bill, why are you so cautious?; Perhaps not
everyone knows that
|
|
|
1997
|
8 |
12 |
p. 1171-1175
5 p.
|
artikel
|
| 11 |
Epidermal growth factor receptor (EGFR) and EGFR mutations, function and
possible role in clinical trials
|
B. Rude Voldborg
|
|
1997
|
8 |
12 |
p. 1197-1206
10 p.
|
artikel
|
| 12 |
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium
thiosulphate protection in ovarian cancer patients with either pathologically
complete response or minimal residual disease
|
R. E. N. van Rijswijk
|
|
1997
|
8 |
12 |
p. 1235-1241
7 p.
|
artikel
|
| 13 |
How much chemotherapy in advanced Hodgkins disease?
|
M. Björkholm
|
|
1997
|
8 |
12 |
p. 1281-1283
3 p.
|
artikel
|
| 14 |
Phase II study of the combination of the novel bioreductive agent,
tirapazamine, with cisplatin in patients with advanced non-small-cell lung
cancer
|
V. A. Miller
|
|
1997
|
8 |
12 |
p. 1269-1271
3 p.
|
artikel
|
| 15 |
Quality of life assessment and clinical decision-making
|
P. Casali
|
|
1997
|
8 |
12 |
p. 1207-1211
5 p.
|
artikel
|
| 16 |
Relationships between biochemical and symptomatic response in a
double-blind randomised trial of pamidronate for metastatic bone disease
|
J. J. F. Vinholes
|
|
1997
|
8 |
12 |
p. 1243-1250
8 p.
|
artikel
|
| 17 |
Single-agent high-dose melphalan salvage therapy for Hodgkins disease:
Cost, safety, and long-term efficacy
|
D. A. Stewart
|
|
1997
|
8 |
12 |
p. 1277-1279
3 p.
|
artikel
|
| 18 |
Suppression of invasive behavior of melanoma cells by stable expression
of anti-sense perlecan cDNA
|
R. Adatia
|
|
1997
|
8 |
12 |
p. 1257-1261
5 p.
|
artikel
|
| 19 |
The bigger the better? ... or what we know and what we still need to
learn about anthracycline dose per course, dose density and cumulative dose
in the treatment of breast cancer
|
L. Biganzoli
|
|
1997
|
8 |
12 |
p. 1177-1182
6 p.
|
artikel
|
| 20 |
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed
acute promyelocytic leukemia patients aged <60 years
|
R. Latagliata
|
|
1997
|
8 |
12 |
p. 1273-1275
3 p.
|
artikel
|
| 21 |
Undergraduate education in Oncology in the Balkans and Middle East
|
N. Pavlidis
|
|
1997
|
8 |
12 |
p. 1281-1281
1 p.
|
artikel
|
Tijdschrift beschrijving